Veeva Systems Inc. – Consensus ‘buy’ rating and 18.5% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Veeva Systems Inc. with ticker code (VEEV) have now 24 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $270.00 and $200.00 with the average target price sitting at $241.47. Now with the previous closing price of $203.78 this indicates there is a potential upside of 18.5%. It’s also worth noting that there is a 50 day moving average of $214.81 and the 200 day moving average is $202.40. The company has a market cap of 32.95B. The current share price for the company is: $203.86 USD

The potential market cap would be $39,040,253,727 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 63.31, revenue per share of $14.72 and a 5.01% return on assets.

Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry. The Company’s offerings span cloud software, data, and business consulting and are designed to meet the needs of its customers and their most strategic business functions from research and development (R&D) to commercialization. The Company’s industry cloud solutions for the life sciences industry are grouped into two major product families: Veeva Development Cloud and Veeva Commercial Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its proprietary Veeva Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical affairs, and marketing functions of a life sciences company. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search